Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 3546 entries
View as:

"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk

Phase: N/A Priority: Normal
NCT ID: NCT00056407 Org: User:
Start: 03/31/03 End: 04/30/09 Due: 04/30/10

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Melrilimab (GSK3772847) in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04366349 Org: User:
Start: 07/21/20 End: 12/21/20 Due: 12/21/21

SB-705498 Dental Pain Study After Tooth Extraction

Phase: N/A Priority: Normal
NCT ID: NCT00281684 Org: User:
Start: 12/07/05 End: 10/03/07 Due: 10/03/08

Efficacy and Safety of the Addition of Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide Inhalation Powder (62.5 or 125mcg) Once-daily Over 12 Weeks.

Phase: N/A Priority: Normal
NCT ID: NCT01772147 Org: User:
Start: 01/31/13 End: 08/31/13 Due: 08/31/14

Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)

Phase: N/A Priority: Normal
NCT ID: NCT00169585 Org: User:
Start: 03/31/05 End: 04/30/07 Due: 04/30/08

Effects of a Common Cold Treatment on Cognitive Function

Phase: N/A Priority: Normal
NCT ID: NCT01466348 Org: User:
Start: 02/28/11 End: 04/30/11 Due: 04/30/12

Dabrafenib/Trametinib, BRAF or BRAF AND MEK Pre-op With BRAF and MEK Post-op, Phase IIB, Melanoma With Brain Mets,Biomarkers and Metabolites

Phase: N/A Priority: Normal
NCT ID: NCT01978236 Org: User:
Start: 04/08/14 End: 04/26/17 Due: 04/26/18

The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00440128 Org: User:
Start: 05/04/07 End: 07/17/08 Due: 07/17/09

Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years

Phase: N/A Priority: Normal
NCT ID: NCT01235975 Org: User:
Start: 11/30/10 End: 08/03/11 Due: 08/03/12

Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00984659 Org: User:
Start: 10/29/09 End: 07/01/10 Due: 07/01/11

Retapamulin Microdialysis Feasibility Study

Phase: N/A Priority: Normal
NCT ID: NCT01812382 Org: User:
Start: 04/02/14 End: 05/27/14 Due: 05/27/15

Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye Drops

Phase: N/A Priority: Normal
NCT ID: NCT00659555 Org: User:
Start: 04/04/08 End: 05/10/08 Due: 05/10/09

A Post-marketing Surveillance Study to Assess the Safety of Cervarix (GlaxoSmithKline [GSK] Biologicals' Human Papillomavirus [HPV] -16/18 Vaccine), When Administered According to the Approved Prescribing Information (PI) in Korea

Phase: N/A Priority: Normal
NCT ID: NCT03671369 Org: User:
Start: 10/02/18 End: 12/01/20 Due: 12/01/21

Study to Assess the Incidence of Intussusception in Children < 2 Years of Age in Singapore

Phase: N/A Priority: Normal
NCT ID: NCT01177839 Org: User:
Start: 05/31/02 End: 07/31/10 Due: 07/31/11

A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05999708 Org: User:
Start: 10/31/23 End: 12/05/24 Due: 12/05/25

A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)

Phase: N/A Priority: Normal
NCT ID: NCT01462292 Org: User:
Start: 10/26/11 End: 11/04/13 Due: 11/04/14

A Study of GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06796907 Org: User:
Start: 03/04/25 End: 04/05/28 Due: 04/05/29

A Proof of Concept Clinical Study to Investigate the Effects of an Experimental Cosmetic Moisturiser on the Barrier Function of Human Skin on the Face and Forearm

Phase: N/A Priority: Normal
NCT ID: NCT03216265 Org: User:
Start: 02/23/17 End: 04/24/17 Due: 04/24/18

To Assess the Excretion Balance and Pharmacokinetics of a Single Oral Dose of [14C]SB-681323 in Healthy Adult Males

Phase: N/A Priority: Normal
NCT ID: NCT00564746 Org: User:
Start: 09/20/07 End: 10/26/07 Due: 10/26/08

A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02345161 Org: User:
Start: 01/23/15 End: 04/07/16 Due: 04/07/17

Safety, Tolerability and Pharmacokinetic Investigation of GSK3882347 in Healthy Participants.

Phase: N/A Priority: Normal
NCT ID: NCT04488770 Org: User:
Start: 08/24/20 End: 05/14/21 Due: 05/14/22

Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study)

Phase: N/A Priority: Normal
NCT ID: NCT00866294 Org: User:
Start: 04/30/09 End: 02/28/10 Due: 02/28/11

A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00319332 Org: User:
Start: 09/30/05 End: 02/28/21 Due: 02/28/22

Immunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-endemic Region

Phase: N/A Priority: Normal
NCT ID: NCT00600782 Org: User:
Start: 02/05/08 End: 12/19/08 Due: 12/19/09

Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy Study

Phase: N/A Priority: Normal
NCT ID: NCT01101555 Org: User:
Start: 05/12/10 End: 11/29/12 Due: 11/29/13